Trade Zepp Health - ZEPP CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.0168 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Zepp Health Corp ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
Prev. Close* | 1.1266 |
Open* | 1.1266 |
1-Year Change* | -37.41% |
Day's Range* | 1.1266 - 1.1466 |
52 wk Range | 1.05-2.19 |
Average Volume (10 days) | 42.34K |
Average Volume (3 months) | 956.18K |
Market Cap | 65.92M |
P/E Ratio | -100.00K |
Shares Outstanding | 244.15M |
Revenue | 487.27M |
EPS | -0.67 |
Dividend (Yield %) | N/A |
Beta | 0.86 |
Next Earnings Date | Nov 20, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Sep 22, 2023 | 1.1466 | 0.0200 | 1.78% | 1.1266 | 1.1466 | 1.1266 |
Sep 21, 2023 | 1.1266 | 0.0300 | 2.74% | 1.0966 | 1.1266 | 1.0966 |
Sep 19, 2023 | 1.1166 | -0.0100 | -0.89% | 1.1266 | 1.1266 | 1.1166 |
Sep 18, 2023 | 1.1466 | 0.0000 | 0.00% | 1.1466 | 1.1466 | 1.1466 |
Sep 15, 2023 | 1.1466 | 0.0000 | 0.00% | 1.1466 | 1.1466 | 1.1466 |
Sep 14, 2023 | 1.1666 | 0.0200 | 1.74% | 1.1466 | 1.1666 | 1.1466 |
Sep 13, 2023 | 1.1466 | 0.0000 | 0.00% | 1.1466 | 1.1466 | 1.1466 |
Sep 12, 2023 | 1.1566 | 0.0000 | 0.00% | 1.1566 | 1.1566 | 1.1566 |
Sep 11, 2023 | 1.1766 | 0.0000 | 0.00% | 1.1766 | 1.1766 | 1.1766 |
Sep 8, 2023 | 1.1766 | 0.0100 | 0.86% | 1.1666 | 1.1866 | 1.1566 |
Sep 7, 2023 | 1.1066 | 0.0300 | 2.79% | 1.0766 | 1.1066 | 1.0566 |
Sep 5, 2023 | 1.1766 | 0.0000 | 0.00% | 1.1766 | 1.1766 | 1.1766 |
Sep 1, 2023 | 1.1566 | 0.0100 | 0.87% | 1.1466 | 1.1566 | 1.1466 |
Aug 31, 2023 | 1.1166 | 0.0000 | 0.00% | 1.1166 | 1.1166 | 1.1166 |
Aug 30, 2023 | 1.1566 | -0.0100 | -0.86% | 1.1666 | 1.1666 | 1.1566 |
Aug 29, 2023 | 1.1166 | 0.0000 | 0.00% | 1.1166 | 1.1166 | 1.1166 |
Aug 28, 2023 | 1.0666 | -0.0100 | -0.93% | 1.0766 | 1.0766 | 1.0566 |
Aug 25, 2023 | 1.1466 | 0.0000 | 0.00% | 1.1466 | 1.1466 | 1.1466 |
Aug 24, 2023 | 1.1566 | 0.0100 | 0.87% | 1.1466 | 1.1566 | 1.1466 |
Aug 23, 2023 | 1.1366 | 0.0000 | 0.00% | 1.1366 | 1.1366 | 1.1366 |
Zepp Health Events
Time (UTC) | Country | Event |
---|---|---|
Monday, November 20, 2023 | ||
Time (UTC) 13:30 | Country US
| Event Q3 2023 Zepp Health Corp Earnings Release Q3 2023 Zepp Health Corp Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 4142.86 | 6250.11 | 6433.36 | 5812.25 | 3645.33 |
Revenue | 4142.86 | 6250.11 | 6433.36 | 5812.25 | 3645.33 |
Cost of Revenue, Total | 3339.75 | 4944.47 | 5100.7 | 4344.51 | 2705.89 |
Gross Profit | 803.116 | 1305.64 | 1332.67 | 1467.74 | 939.45 |
Total Operating Expense | 4566.96 | 6156.17 | 6202.65 | 5208.37 | 3287.21 |
Selling/General/Admin. Expenses, Total | 696.236 | 696.619 | 620.46 | 430.437 | 310.511 |
Research & Development | 517.122 | 515.081 | 538.009 | 430.822 | 263.22 |
Operating Income | -424.1 | 93.942 | 230.718 | 603.884 | 358.129 |
Interest Income (Expense), Net Non-Operating | 7.747 | -14.691 | 58.443 | 35.3 | 19.716 |
Other, Net | 43.82 | 27.418 | -23.552 | 13.186 | 8.768 |
Net Income Before Taxes | -372.533 | 106.669 | 265.609 | 652.37 | 386.613 |
Net Income After Taxes | -306.658 | 95.924 | 234.455 | 574.483 | 334.577 |
Equity In Affiliates | 17.657 | 41.028 | -4.749 | -1.112 | 1.743 |
Net Income Before Extra. Items | -288.308 | 137.803 | 228.753 | 575.196 | 340.046 |
Net Income | -288.308 | 137.803 | 228.753 | 575.196 | 340.046 |
Total Adjustments to Net Income | -2.45 | -226.556 | |||
Income Available to Common Excl. Extra. Items | -288.308 | 137.803 | 228.753 | 572.746 | 113.49 |
Income Available to Common Incl. Extra. Items | -288.308 | 137.803 | 228.753 | 572.746 | 113.49 |
Diluted Net Income | -288.308 | 137.803 | 228.753 | 572.746 | 113.49 |
Diluted Weighted Average Shares | 246.283 | 264.369 | 260.352 | 255.959 | 225.035 |
Diluted EPS Excluding Extraordinary Items | -1.17064 | 0.52125 | 0.87863 | 2.23765 | 0.50432 |
Dividends per Share - Common Stock Primary Issue | |||||
Diluted Normalized EPS | -1.13406 | 0.52125 | 0.687 | 2.24659 | 0.53351 |
Minority Interest | 0.693 | 0.851 | -0.953 | 1.825 | 3.726 |
Total Extraordinary Items | |||||
Unusual Expense (Income) | 13.858 | 0 | -56.522 | 2.6 | 7.59 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 648.343 | 645.183 | 1071.73 | 1205.79 | 1108.29 |
Revenue | 648.343 | 645.183 | 1071.73 | 1205.79 | 1108.29 |
Cost of Revenue, Total | 505.801 | 542.338 | 849.885 | 975.106 | 909.945 |
Gross Profit | 142.542 | 102.845 | 221.846 | 230.687 | 198.343 |
Total Operating Expense | 720.716 | 796.091 | 1156.54 | 1279.05 | 1218.89 |
Selling/General/Admin. Expenses, Total | 125.622 | 135.879 | 178.456 | 176.565 | 179.949 |
Research & Development | 89.293 | 117.874 | 114.341 | 127.382 | 128.991 |
Operating Income | -72.373 | -150.908 | -84.809 | -73.26 | -110.597 |
Interest Income (Expense), Net Non-Operating | -2.579 | -5.824 | 7.786 | -19.241 | -23.373 |
Other, Net | -0.783 | -1.985 | -0.514 | 38.269 | 2.32 |
Net Income Before Taxes | -75.735 | -158.717 | -77.537 | -54.232 | -131.65 |
Net Income After Taxes | -64.123 | -133.983 | -75.033 | -20.626 | -118.632 |
Minority Interest | 0.185 | 0.194 | 0.195 | 0.127 | 0.237 |
Equity In Affiliates | -6.003 | -2.931 | -0.71 | 3.409 | 11.45 |
Net Income Before Extra. Items | -69.941 | -136.72 | -75.548 | -17.09 | -106.945 |
Net Income | -69.941 | -136.72 | -75.548 | -17.09 | -106.945 |
Income Available to Common Excl. Extra. Items | -69.941 | -136.72 | -75.548 | -17.09 | -106.945 |
Income Available to Common Incl. Extra. Items | -69.941 | -136.72 | -75.548 | -17.09 | -106.945 |
Diluted Net Income | -69.941 | -136.72 | -75.548 | -17.09 | -106.945 |
Diluted Weighted Average Shares | 243.551 | 245.134 | 244.846 | 245.117 | 245.703 |
Diluted EPS Excluding Extraordinary Items | -0.28717 | -0.55774 | -0.30855 | -0.06972 | -0.43526 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.28717 | -0.55774 | -0.27176 | -0.06972 | -0.43526 |
Unusual Expense (Income) | 13.858 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 2958.55 | 3930.95 | 4827.87 | 4392.45 | 2857.46 |
Cash and Short Term Investments | 920.948 | 1492.85 | 2296.78 | 1820.3 | 1589.25 |
Cash & Equivalents | 886.632 | 1473.5 | 2278.35 | 1803.12 | 1538.77 |
Short Term Investments | 34.316 | 19.351 | 18.43 | 17.187 | 50.482 |
Total Receivables, Net | 870.316 | 1087.93 | 1280 | 1663.96 | 757.474 |
Accounts Receivable - Trade, Net | 820.717 | 832.698 | 1158.25 | 1610.11 | 715.324 |
Total Inventory | 1021.92 | 1249.33 | 1217.54 | 893.806 | 484.622 |
Prepaid Expenses | 55.44 | 58.994 | 26.737 | 11.724 | 11.623 |
Other Current Assets, Total | 89.921 | 41.856 | 6.816 | 2.661 | 14.484 |
Total Assets | 5267.64 | 6085.5 | 5903.72 | 5174.74 | 3258.48 |
Property/Plant/Equipment, Total - Net | 166.178 | 242.308 | 275.784 | 173.032 | 40.042 |
Property/Plant/Equipment, Total - Gross | 278.416 | 313.14 | 312.171 | 194.47 | 52.071 |
Accumulated Depreciation, Total | -112.238 | -70.832 | -36.387 | -21.438 | -12.029 |
Goodwill, Net | 66.081 | 61.055 | 62.515 | 5.93 | 5.93 |
Intangibles, Net | 123.3 | 135.582 | 145.213 | 85.753 | 63.722 |
Long Term Investments | 1686.63 | 1552.59 | 443.986 | 406.099 | 208.949 |
Other Long Term Assets, Total | 260.575 | 163.012 | 148.355 | 111.477 | 82.382 |
Total Current Liabilities | 1668.67 | 2152.13 | 2789.67 | 2481.8 | 1387.69 |
Accounts Payable | 497.563 | 1367.43 | 1962.52 | 2014.72 | 1074.8 |
Accrued Expenses | 92.646 | 139.701 | 134.678 | 256.077 | 154.303 |
Notes Payable/Short Term Debt | 968.438 | 461.795 | 504.671 | 2.184 | 38.936 |
Other Current Liabilities, Total | 110.021 | 183.207 | 187.805 | 208.819 | 119.652 |
Total Liabilities | 2595.12 | 3165.15 | 3173.46 | 2673.99 | 1447.57 |
Total Long Term Debt | 684.21 | 726.851 | 60 | 0 | 0 |
Deferred Income Tax | 35.552 | 26.909 | 22.374 | 5.399 | 4.962 |
Minority Interest | 12.399 | 13.092 | 0 | -3.162 | -1.337 |
Other Liabilities, Total | 194.292 | 246.17 | 301.413 | 189.956 | 56.249 |
Total Equity | 2672.52 | 2920.35 | 2730.26 | 2500.75 | 1810.92 |
Preferred Stock - Non Redeemable, Net | |||||
Common Stock | 0.162 | 0.159 | 0.157 | 0.155 | 0.151 |
Additional Paid-In Capital | 1690.88 | 1641.54 | 1552.11 | 1478.9 | 1373.58 |
Retained Earnings (Accumulated Deficit) | 942.848 | 1271.17 | 1133.37 | 910.612 | 340.046 |
Other Equity, Total | 105.796 | 29.271 | 44.624 | 111.081 | 97.141 |
Total Liabilities & Shareholders’ Equity | 5267.64 | 6085.5 | 5903.72 | 5174.74 | 3258.48 |
Total Common Shares Outstanding | 251.201 | 251.201 | 250.145 | 247.52 | 241.68 |
Redeemable Preferred Stock | 0 | ||||
Long Term Debt | 684.21 | 726.851 | 60 | ||
Treasury Stock - Common | -67.163 | -21.798 | |||
Note Receivable - Long Term | 6.333 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 2595.02 | 2958.55 | 3456.28 | 3777.23 | 3654.67 |
Cash and Short Term Investments | 996.258 | 920.948 | 983.519 | 996.586 | 2557.6 |
Cash & Equivalents | 961.478 | 886.632 | 945.509 | 959.578 | 1027.01 |
Short Term Investments | 34.78 | 34.316 | 38.01 | 37.008 | 1530.59 |
Total Receivables, Net | 626.966 | 820.717 | 856.889 | 1096.64 | 715.018 |
Accounts Receivable - Trade, Net | 626.966 | 820.717 | 856.889 | 1096.64 | 715.018 |
Total Inventory | 799.933 | 1021.92 | 1375.12 | 1515.68 | 36.08 |
Prepaid Expenses | 126.873 | 108.252 | 175.524 | 125.785 | 315.129 |
Other Current Assets, Total | 44.988 | 86.708 | 65.231 | 42.545 | 30.844 |
Total Assets | 4898.93 | 5267.64 | 5821.07 | 6101.73 | 5906 |
Property/Plant/Equipment, Total - Net | 142.142 | 166.178 | 189.889 | 207.942 | 224.904 |
Goodwill, Net | 65.797 | 66.081 | 68.153 | 64.173 | 60.736 |
Intangibles, Net | 119.038 | 123.3 | 128.873 | 129.497 | 131.592 |
Long Term Investments | 1681.38 | 1686.63 | 1713.39 | 1699.39 | 1635.54 |
Other Long Term Assets, Total | 289.205 | 260.575 | 264.487 | 223.505 | 198.56 |
Total Current Liabilities | 1204.01 | 1668.67 | 2096.13 | 2274.51 | 2158.69 |
Accounts Payable | 364.18 | 497.563 | 869.973 | 1002.44 | 1063.52 |
Accrued Expenses | 157.007 | 197.819 | 210.928 | 219.727 | 292.801 |
Notes Payable/Short Term Debt | 669.542 | 968.438 | 971.228 | 1010.84 | 779.755 |
Other Current Liabilities, Total | 13.279 | 4.848 | 43.998 | 41.506 | 22.608 |
Total Liabilities | 2354.31 | 2595.12 | 3050.16 | 3340.64 | 3106.73 |
Total Long Term Debt | 923.982 | 684.21 | 688.063 | 747.266 | 670.309 |
Long Term Debt | 923.982 | 684.21 | 688.063 | 747.266 | 670.309 |
Deferred Income Tax | 34.658 | 35.552 | 38.928 | 38.874 | 30.176 |
Minority Interest | 12.205 | 12.399 | 12.594 | 12.721 | 12.958 |
Other Liabilities, Total | 179.458 | 194.292 | 214.45 | 267.274 | 234.602 |
Total Equity | 2544.62 | 2672.52 | 2770.91 | 2761.09 | 2799.27 |
Common Stock | 0.163 | 0.162 | 0.159 | 0.159 | 0.159 |
Additional Paid-In Capital | 1714.88 | 1690.88 | 1675.69 | 1667.39 | 1654.76 |
Retained Earnings (Accumulated Deficit) | 806.128 | 942.848 | 1018.4 | 1035.49 | 1142.43 |
Other Equity, Total | 96.252 | 105.796 | 135.584 | 114.233 | 46.802 |
Total Liabilities & Shareholders’ Equity | 4898.93 | 5267.64 | 5821.07 | 6101.73 | 5906 |
Total Common Shares Outstanding | 244.152 | 251.201 | 251.201 | 251.201 | 251.201 |
Treasury Stock - Common | -72.803 | -67.163 | -58.918 | -56.176 | -44.88 |
Note Receivable - Long Term | 6.348 | 6.333 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -289.001 | 136.952 | 229.706 | 573.371 | 336.32 |
Cash From Operating Activities | -787.643 | -232.435 | 157.302 | 427.999 | 707.605 |
Cash From Operating Activities | 58.618 | 51.884 | 27.129 | 9.409 | 5.773 |
Deferred Taxes | -65.22 | -18.694 | -10.442 | -27.8 | -32.895 |
Non-Cash Items | 71.759 | 122.289 | 120.876 | 114.907 | 138.256 |
Cash Taxes Paid | 3.443 | 74.377 | 82.406 | 91.732 | 52.063 |
Changes in Working Capital | -563.799 | -524.866 | -209.967 | -249.694 | 259.708 |
Cash From Investing Activities | -42.258 | -1069.29 | -206.88 | -112.703 | -324.841 |
Capital Expenditures | -9.92 | -53.082 | -84.774 | -46.121 | -69.153 |
Other Investing Cash Flow Items, Total | -32.338 | -1016.21 | -122.106 | -66.582 | -255.688 |
Cash From Financing Activities | 289.198 | 551.077 | 564.671 | 25.609 | 639.17 |
Issuance (Retirement) of Stock, Net | -53.216 | -8.298 | 0.933 | 652.391 | |
Issuance (Retirement) of Debt, Net | 421.624 | 520.18 | 564.671 | -20 | -13.221 |
Foreign Exchange Effects | 4.504 | -15.564 | -43.334 | 11.274 | 60.357 |
Net Change in Cash | -536.199 | -766.211 | 471.759 | 352.179 | 1082.29 |
Amortization | 7.806 | 0.443 | |||
Cash Interest Paid | 55.847 | 47.132 | 14.858 | 0.286 | 1.31 |
Financing Cash Flow Items | -39.195 | 39.195 | 44.676 | ||
Total Cash Dividends Paid | -40.015 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Allspring Global Investments, LLC | Investment Advisor/Hedge Fund | 16.1779 | 5134210 | 0 | 2023-06-30 | LOW |
Fidelity International | Investment Advisor | 5.7593 | 1827770 | -170313 | 2023-06-30 | LOW |
FIL Investment Management (Hong Kong) Limited | Investment Advisor | 3.8846 | 1232834 | -37407 | 2023-06-30 | MED |
Huang (Wang) | Individual Investor | 3.3559 | 1065019 | 0 | 2022-12-31 | |
Florida State Board of Administration | Pension Fund | 1.4779 | 469042 | -20500 | 2022-09-30 | LOW |
SEI Investments Management Corporation | Investment Advisor/Hedge Fund | 1.1309 | 358906 | 0 | 2023-06-30 | LOW |
Axxion S.A. | Investment Advisor | 0.3151 | 100000 | 0 | 2023-07-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.3094 | 98200 | -1400 | 2023-06-30 | HIGH |
Citadel Advisors LLC | Hedge Fund | 0.2891 | 91762 | 30192 | 2023-06-30 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.0984 | 31239 | -8855 | 2023-06-30 | HIGH |
Mandatum Henkivakuutusosakeyhtiö | Insurance Company | 0.0851 | 27000 | 0 | 2023-06-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.0772 | 24510 | -50153 | 2023-06-30 | LOW |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 0.0766 | 24307 | -3647 | 2023-06-30 | MED |
LPL Financial LLC | Investment Advisor | 0.0687 | 21803 | -1350 | 2023-06-30 | LOW |
Gesinter S.G.I.I.C., S.A. | Investment Advisor | 0.068 | 21582 | 11611 | 2023-03-31 | MED |
Millennium Management LLC | Hedge Fund | 0.0536 | 16997 | -6656 | 2023-06-30 | HIGH |
Hansen & Heinrich Aktiengesellschaft | Investment Advisor | 0.0473 | 15000 | 0 | 2022-04-30 | MED |
Morgan Stanley & Co. LLC | Research Firm | 0.0472 | 14968 | -6616 | 2023-06-30 | MED |
AQR Capital Management, LLC | Investment Advisor/Hedge Fund | 0.0255 | 8091 | -23282 | 2021-12-31 | MED |
Osaic Holdings, Inc. | Investment Advisor | 0.0115 | 3640 | -145 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Zepp Health Company profile
About Zepp Health Corp - ADR
Zepp Health Corp, formerly Huami Corp, is a company committed to connect health with technology. It has developed a platform of proprietary technology including artificial intelligence (AI) chips, biometric sensors, and health data algorithms. It is engaged in developing smart wearable technology. It designs and develops biometric and activity data-driven fitness and smart watches. It markets its products under the brand name, Amazfit and is the sole partner for Xiaomi wearable products. The products includes Amazfit BIP, Amazfit pace, Amazfit equator, Amazfit ARC, and accessories, such as sports bands, watch straps, ear buds, charging units, and core trackers. The smart watches provides activity tracking, sleep tracking, smart notifications from mobile devices, GPS, heart rate sensing, water resistance, wireless syncing with mobile phones. It also provides a mobile application to keep track of the fitness information, set alarms and receive call notifications on the smart watch.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Zepp Health Corp - ADR revenues decreased 3% to RMB6.25B. Net income decreased 40% to RMB137.8M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Interest income decrease of 64% to RMB16.7M (income), Gain from fair value change of long-term decrease from RMB12.3M (income) to RMB0K.
Industry: | Phones & Handheld Devices (NEC) |
Building B2, Zhong'an Chuanggu Technology Park, No.900 Wangjiang West Rd
HEFEI
ANHUI 230088
CN
Income Statement
- Annual
- Quarterly
News

EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023
Cable coils near lows ahead of Fed and BoE rate decisions
It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.
14:16, 19 September 2023
FTSE 100 Technical Outlook - 18 September 2023
In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.
06:55, 19 September 2023
Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally
The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.
13:46, 15 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com